Previous economic studies of Helicobacter pylori eradication in dyspepsia and peptic ulcer disease have not measured quality of life using utilities (preference probabilities), which are needed to compare the cost-effectiveness of such treatment to other health care interventions. The goals of this study were to measure quality of life in patients with dyspepsia or peptic ulcer and apply these measurements to published models of disease management to determine cost-effectiveness in dollars per quality-adjusted life year (QALY) gained. Methods : Utilities for dyspepsia and peptic ulcer disease were measured in adult patients (n = 73) on chronic acid suppression for peptic ulcer or ulcer-like dyspepsia. Median utility values were applied to t...
Current clinical consensus supports an initial Helicobacter pylori (HP) “test and treat” approach wh...
AbstractBackgroundClinical trials provide evidence of the high effectiveness of Helicobacter pylori ...
Background: Helicobacter pylori, the cause of most peptic ulcer diseases, infects approximately 50% ...
Background: In western European countries, most dyspeptic patients are initially managed by their ge...
Objective: We initiated a cost-minimisation modelling study to compare the costs of strategies based...
Clinical data comparing diagnostic strategies in the management of Helicobacter pylori-associated di...
BACKGROUND AND AIM: We conducted a systematic review and economic analysis to ascertain the efficacy...
Due to its prevalence, impact on quality-of-life and the associated significant health resource util...
BACKGROUND: The objective of this research was to evaluate the outcomes and costs of alternative app...
Objectives: To model cost-effectiveness of near patient tests (NPT) for H. pylori in screening prove...
Eradication of Helicobacter pylori (Hp) without prior Hp diagnostics ia a cost-effective strategy in...
Objective: To compare the costs and outcomes of two different protocols of three consecutive combina...
OBJECTIVE: To determine the impact of a community based Helicobacter pylori screening and eradicatio...
BACKGROUND: A policy of withholding endoscopy in Helicobacter pylori sero-negative dyspeptic patient...
Background: Helicobacter pylori may cause many gastrointestinal problems in developing countries suc...
Current clinical consensus supports an initial Helicobacter pylori (HP) “test and treat” approach wh...
AbstractBackgroundClinical trials provide evidence of the high effectiveness of Helicobacter pylori ...
Background: Helicobacter pylori, the cause of most peptic ulcer diseases, infects approximately 50% ...
Background: In western European countries, most dyspeptic patients are initially managed by their ge...
Objective: We initiated a cost-minimisation modelling study to compare the costs of strategies based...
Clinical data comparing diagnostic strategies in the management of Helicobacter pylori-associated di...
BACKGROUND AND AIM: We conducted a systematic review and economic analysis to ascertain the efficacy...
Due to its prevalence, impact on quality-of-life and the associated significant health resource util...
BACKGROUND: The objective of this research was to evaluate the outcomes and costs of alternative app...
Objectives: To model cost-effectiveness of near patient tests (NPT) for H. pylori in screening prove...
Eradication of Helicobacter pylori (Hp) without prior Hp diagnostics ia a cost-effective strategy in...
Objective: To compare the costs and outcomes of two different protocols of three consecutive combina...
OBJECTIVE: To determine the impact of a community based Helicobacter pylori screening and eradicatio...
BACKGROUND: A policy of withholding endoscopy in Helicobacter pylori sero-negative dyspeptic patient...
Background: Helicobacter pylori may cause many gastrointestinal problems in developing countries suc...
Current clinical consensus supports an initial Helicobacter pylori (HP) “test and treat” approach wh...
AbstractBackgroundClinical trials provide evidence of the high effectiveness of Helicobacter pylori ...
Background: Helicobacter pylori, the cause of most peptic ulcer diseases, infects approximately 50% ...